Oncology Impact Fund (Cayman) Management L.P.
SEC CIK 1721036 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CGEM | Cullinan Therapeutics, Inc. | 10% | 7.76M | — | $4.40M | 2 | 2021-08-23 | 2021-08-27 |
Most active insiders at CGEM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lynx1 Capital Management LP | 10% | $11.93M | — |
| 2 | Michaelson Jennifer | CSO | — | $1.62M |
| 3 | Nichols Weston | 10% | $1.39M | — |
| 4 | AHMED NADIM | Pres, CEO, Dir | — | $518.0K |
| 5 | Jones Jeffrey Alan | Chief Medical Off | — | $178.9K |
| 6 | SUMER JACQUELYN L | CLO | — | $136.7K |
| 7 | Fenton Mary Kay | CFO | — | $59.9K |
Oncology Impact Fund (Cayman) Management L.P. made no open-market trades at CGEM in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-08-31 | 2021-08-27+ | CGEM | Cullinan Therapeutics, Inc. | Oncology Impact Fund (Cayman) Management L.P. | 10% | S - Sale | $29.24 | -44.4K | 7.76M | -0.6% | -$1.30M |
| M | 2021-08-25 | 2021-08-23+ | CGEM | Cullinan Therapeutics, Inc. | Oncology Impact Fund (Cayman) Management L.P. | 10% | S - Sale | $29.29 | -105.9K | 7.81M | -1% | -$3.10M |
Purchase Sale Sale after option exercise All abbreviations